<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta content="text/html; charset=utf-8">
</head>
<body bgcolor="#FFFFFF">
Scholars have been building on the work of other scholars, e.g. citing, paraphrasing, building on the ideas of others, for a very long time. This tradition predates copyright, is compatible with All Rights Reserved copyright, and certainly predates Creative
Commons licensing, which is only about 15 years old.
<div><br>
</div>
<div>Use of ND simply indicates that the author is not granting additional derivative rights. I argue that ND is often in the best interests of advancing our knowledge. For example, one type of derivative that would make sense in the scholarly context is a
downstream volunteer co-author, using the original, updating or changing the work, including the original authors and themselves as co-authors. Use of ND is one way to signal to potential downstream volunteer co-authors that this would not be welcome. This
is one of the reasons I suggest that OA activists who use or advocate for CC licenses should embrace ND.</div>
<div><br>
</div>
<div>I also suggest that CC is not the simple solution for OA it appears to be, and I do not recommend paying commercial companies like Elsevier for works to be licensed CC.</div>
<div><br>
</div>
<div>best,</div>
<div><br>
</div>
<div>Heather Morrison </div>
<div>
<div dir="auto"><br>
</div>
<div dir="auto"><br>
</div>
</div>
<div><br>
</div>
<div><br>
</div>
<div>-------- Original message --------</div>
<div>From: Jevan Pipitone <email1@jevan.com.au> </div>
<div>Date: 2017-06-18 2:00 PM (GMT-05:00) </div>
<div>To: "Global Open Access List (Successor of AmSci)" <goal@eprints.org> </div>
<div>Subject: Re: [GOAL] Elsevier's interpretation of CC BY-NC-ND </div>
<div><br>
</div>
<div>
<p><font color="#000000">Sorry - sending this again - since I forgot to add the list email to it.<br>
</font></p>
<p>Re: <font color="#000000"><font color="#000000">Creative Commons-Attribution-Noncommercial-No Derivatives (CC-BY-NC-ND)</font></font></p>
<p><font color="#000000">The fact that it says "No Derivatives" </font><font color="#000000">seems a concern for example sometimes researchers can publish a summary of other peoples articles and then include all the articles used in the references. But if it
says "No Derivatives" does this mean the articles written by other people cannot be used to contribute towards your research, in which case, what is the point in reading them? Also part of the point of reading an article is to gain ideas from other people
which can then be used to create new things by the researcher, but, this is potentially a "derivative" work since it can build on the work of others. So I think there is a problem there too.<br>
</font></p>
Jevan.<br>
<br>
<div class="moz-cite-prefix">On Sun 18-Jun-17 10:29 PM, Richard Poynder wrote:<br>
</div>
<blockquote type="cite">
<div dir="ltr">
<div class="gmail_default" style="">
<p class="MsoNormal"><font color="#000000">On a related topic, this poster might be of interest to list members:<span></span></font></p>
<p class="MsoNormal"><font color="#000000"><br>
</font></p>
<p class="MsoNormal"><b><font color="#000000">Exploiting Elsevier’s Creative Commons License Requirement to Subvert Embargo<span></span></font></b></p>
<p class="MsoNormal"><b><font color="#000000"><br>
</font></b></p>
<p class="MsoNormal"><font color="#000000">"In the last round of author sharing policy revisions, Elsevier created a labyrinthine title-by-title embargo structure requiring embargoes from 12-48 months for author sharing via institutional repository (IR), while
permitting immediate sharing via author's personal website or blog. At the same time, all pre-publication versions are to bear a Creative Commons-Attribution-Noncommercial-No Derivatives (CC-BY-NC-ND) license. </font></p>
<p class="MsoNormal"><font color="#000000"><br>
</font></p>
<p class="MsoNormal"><font color="#000000">"At the time this policy was announced, it was rightly criticized by many in the scholarly communication community as overly complicated and unnecessary. However, this CC licensing requirement creates an avenue for
subverting the embargo in the IR to achieve quicker open distribution of the author's accepted manuscript. </font></p>
<p class="MsoNormal"><font color="#000000"><br>
</font></p>
<p class="MsoNormal"><font color="#000000">"In short, authors may post an appropriately licensed copy on their personal site, at which point we may deposit without embargo in the IR, not through the license granted in the publication agreement, but through
the CC license on the author's version, which the sharing policy mandates. This poster will outline this issue, our experimentation with application, and engage viewers in questions regarding its potential risks, benefits, and workflows."<span></span></font></p>
<p class="MsoNormal"><font color="#000000"> <span></span></font></p>
<p class="MsoNormal"><a href="https://kuscholarworks.ku.edu/handle/1808/24107"><font color="#000000">https://kuscholarworks.ku.edu/handle/1808/24107</font></a><font size="4" style="color:rgb(0,0,255)"><span></span></font></p>
</div>
<div class="gmail_default" style=""><br>
</div>
<div class="gmail_default" style=""></div>
<div class="gmail_default" style=""><br>
</div>
</div>
<div class="gmail_extra"><br>
<div class="gmail_quote">On 18 June 2017 at 12:24, Mittermaier, Bernhard <span dir="ltr">
<<a href="mailto:b.mittermaier@fz-juelich.de" target="_blank">b.mittermaier@fz-juelich.de</a>></span> wrote:<br>
<blockquote class="gmail_quote" style="margin:0 0 0
.8ex; border-left:1px #ccc solid; padding-left:1ex">
<div lang="DE">
<div class="m_4621708708008501627WordSection1">
<p class="MsoNormal"><span lang="EN-GB">Dear colleagues,</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">on sharing in file-sharing networks, Creatice Commons explain:
</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">“Can I share CC-licensed material on file-sharing networks?</span></p>
<p class="MsoNormal"><span lang="EN-GB">Yes. All CC licenses allow redistribution of the unmodified material by any means, including distribution via file-sharing networks. Note that file-trading is expressly considered to be noncommercial for purposes of compliance
with the NC licenses. Barter of NC-licensed material for other items of value is not permitted.”</span></p>
<p class="MsoNormal"><span lang="EN-GB"><a href="https://creativecommons.org/faq/#can-i-share-cc-licensed-material-on-file-sharing-networks" target="_blank">https://creativecommons.org/<wbr>faq/#can-i-share-cc-licensed-<wbr>material-on-file-sharing-<wbr>networks</a>
</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">The “Elsevier Sharing Rules” say</span></p>
<p class="MsoNormal"><span lang="EN-GB">“CC-BY-NC-ND licensed articles may be shared on non-commercial platforms only.”</span></p>
<p class="MsoNormal"><span lang="EN-GB"><a href="http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm%7CStartTopic=Content%2Fsharing_pubs.htm%7CSkinName=svs_SD" target="_blank">http://help.sciencedirect.com/<wbr>flare/sdhelp_Left.htm#CSHID=<wbr>password.htm|StartTopic=<wbr>Content%2Fsharing_pubs.htm|<wbr>SkinName=svs_SD</a></span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">and again in the table at the bottom of that webpage: “Public posting on commercial platforms (e.g.,
<a href="http://www.researchgate.net" target="_blank">www.researchgate.net</a>, <a href="http://www.academia.edu" target="_blank">
www.academia.edu</a>)” :not allowed</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">I’ve been asking Alicia Wise, on what grounds why Elsevier takes that position. She replied:
</span></p>
<p class="MsoNormal"><span lang="EN-GB">„Both ResearchGate & <a href="http://academia.edu" target="_blank">
academia.edu</a> use content commercially to sell advertising & services around the content they disseminate” and “Both ResearchGate &
</span><a href="https://t.co/IQgdiiCF1s" title="http://Academia.edu" target="_blank"><span class="m_4621708708008501627invisible"><span lang="EN-GB" style="color:blue">academia.edu</span></span></a>
<span lang="EN-GB">are problems in Germany as they go beyond private use to make NC content publicly available” (</span><a href="https://twitter.com/wisealic/status/874284792275140609" target="_blank"><span lang="EN-GB">https://twitter.com/wisealic/<wbr>status/874284792275140609</span></a><span lang="EN-GB">
and <a href="https://twitter.com/wisealic/status/874284916644696066" target="_blank">
https://twitter.com/wisealic/<wbr>status/874284916644696066</a> )</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">My interpretation of the CC licence is that sharing of CC BY-NC-ND article by commercial platforms is OK as long as they don’t sell the articles (which they don’t do).
</span></p>
<p class="MsoNormal"><span lang="EN-GB">But apart from that - what authors are doing is IMHO definitely not prohibited because they have no commercial gain whatsoever.</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">What do you think?</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p class="MsoNormal"><span lang="EN-GB">Kind regards</span></p>
<p class="MsoNormal"><span>Bernhard</span></p>
<p class="MsoNormal"><span>##############################<wbr>#############</span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>Dr. Bernhard Mittermaier</span></p>
<p class="MsoNormal"><span>Forschungszentrum Jülich GmbH</span></p>
<p class="MsoNormal"><span lang="EN-GB">Leiter der Zentralbibliothek / Head of the Central Library</span></p>
<p class="MsoNormal"><span>52425 Jülich</span></p>
<p class="MsoNormal"><span>Tel <a href="tel:+49%202461%20613013" value="+492461613013" target="_blank">
++49-2461-613013</a></span></p>
<p class="MsoNormal"><span>Fax <a href="tel:+49%202461%20616103" value="+492461616103" target="_blank">
++49-2461-616103</a></span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal" style="margin-bottom:12.0pt"><span>Sitz der Gesellschaft: Juelich<br>
Eingetragen im Handelsregister des Amtsgerichts Dueren Nr. HR B 3498<br>
Vorsitzender des Aufsichtsrats: MinDir Dr. Karl Eugen Huthmacher<br>
Geschaeftsfuehrung: Prof. Dr.-Ing. Wolfgang Marquardt (Vorsitzender),<br>
Karsten Beneke (stellv. Vorsitzender), Prof. Dr.-Ing. Harald Bolt,<br>
Prof. Dr. Sebastian M. Schmidt</span></p>
<p class="MsoNormal"> </p>
</div>
</div>
<br>
______________________________<wbr>_________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" rel="noreferrer" target="_blank">http://mailman.ecs.soton.ac.<wbr>uk/mailman/listinfo/goal</a><br>
<br>
</blockquote>
</div>
<br>
<br clear="all">
<div><br>
</div>
-- <br>
<div class="gmail_signature">Richard Poynder<br>
<a href="http://www.richardpoynder.co.uk" target="_blank">www.richardpoynder.co.uk</a></div>
</div>
<br>
<fieldset class="mimeAttachmentHeader"></fieldset> <br>
<pre>_______________________________________________
GOAL mailing list
<a class="moz-txt-link-abbreviated" href="mailto:GOAL@eprints.org">GOAL@eprints.org</a>
<a class="moz-txt-link-freetext" href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a>
</pre>
</blockquote>
<br>
<div class="moz-signature">-- <br>
<style>
<!--
a.webpage
{color:#C23AFF}
a.email
{color:#008000}
-->
</style>
<p><br>
</p>
<p><br>
</p>
<p><br>
</p>
<p><br>
</p>
<center><img src="cid:part16.DB548166.99BE7686@jevan.com.au" width="92"><br>
<img src="cid:part17.D8019FCC.00531A40@jevan.com.au" width="174"><br>
<div style="color:#0080CA">Jevan Pipitone<br>
MIT SE (UC), GradDip IT (UC), BSc (ANU), GradCert Rsch Methods & Des (UC)<br>
C#.NET/VB.NET Developer, ASP.NET MySql/MS Sql C#/VB Database Driven Websites, IT Research, IT Support, IT Tutoring<br>
</div>
<a class="webpage" href="http://www.jevan.com.au/" target="_blank">http://www.jevan.com.au/</a><br>
<a class="email" href="mailto:email1@jevan.com.au" target="_blank">email1@jevan.com.au</a><br>
<div style="color:#0000FF">Tel: (02) 6176 1285 / 0498 627 366<br>
(+612 6176 1285 / +61 498 627 366)<br>
Skype: jevanp<br>
Canberra, Australia<br>
</div>
<p><br>
<img src="cid:part20.39B9650A.32200250@jevan.com.au" width="425"><br>
</p>
</center>
</div>
<img src="http://ts.msgtag.net/bf/lxktztyh/yyyDD/ddrBbuDniaoAFpxvn.gif" alt=" " border="0" id="MSGTAGImage">
</div>
</body>
</html>